US Pharma MarketingFTC clears Ascension's $3.9B AmSurg purchase, but requires some ASC divestitures
Ascension’s $3.9 billion plan to acquire ambulatory surgery management services company AmSurg has received a green light from the Federal Trade Commission, so long as the nonprofit health system d The federal regulator said it will permit a deal to create the country's third-largest ASC platform to go forward, so long as seven specific ASCs in threatened markets are divested.
The federal regulator said it will permit a deal to create the country's third-largest ASC platform to go forward, so long as seven specific ASCs in threatened markets are divested.
Source: Fierce Healthcare